You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九強生物(300406.SZ):國藥投資追加承諾定增股票鎖定期36個月
格隆匯 05-12 15:51

格隆匯5月12日丨九強生物(300406.SZ)公佈,公司擬向中國醫藥投資有限公司(下稱“國藥投資”)非公開發行股份不超過8720.9302萬股(含),募集資金總額不超過12億元,扣除發行費用後擬全部用於補充流動資金,國藥投資認購此次發行的股票自此次發行結束之日起18個月內不得轉讓。

公司近日收到國藥投資出具的《關於自願延長鎖定期的承諾》,基於對公司研發能力、行業地位以及體外診斷試劑行業發展前景的認可,國藥投資願為公司的未來發展提供長期支持,進一步促進我國體外診斷行業實力的提升。因此,在前述基礎上,國藥投資自願追加承諾其所認購的此次非公開發行的股份自此次非公開發行結束之日起36個月內不得轉讓。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account